RankAlpha logo
Back to Rankings

INAB

IN8bioC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
INAB vs peer average
64/100
INAB vs. peer average (C vs. D)
Grade spread
A 1 · B 1 · C 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PHIO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $12.55M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPHIOPhio
INAB
IN8bio
PHIO
Phio
Grade
C
B
Momentum
42
87
Value
58
58
Sentiment
-
33
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs PHIO

INAB / PHIO
Grade Position
In line
INAB vs. peer average (C vs. D)
64/100
Momentum
42
PHIO
Value
58
INAB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs INAB
1
PHIO
Phio Pharmaceuticals Corp Common
B
80/100
-1
2
AKTX
Akari Therapeutics Plc ADR
F
20/100
+2
3
INTS
Intensity Therapeutics Inc Common
F
20/100
+2
4
PBM
Psyence Biomedical Ltd Common
F
20/100
+2
5
XCUR
Exicure Inc Common
C
60/100
Even
PHIO is the first peer returned for this comparison set.